American Lithium
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Don’t underestimate the relevant R-I study results creating

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jfmcrr Member Profile
 
Followed By 5
Posts 2,238
Boards Moderated 0
Alias Born 10/12/13
160x600 placeholder
Gibbs Law Group Files Class Action Lawsuit Alleging Violations of Federal Securities Laws Business Wire - 2/22/2019 6:18:00 PM
Amarin To Report Fourth Quarter and Full Year 2018 Results and Host Conference Call on February 27, 2019 GlobeNewswire Inc. - 2/19/2019 6:00:00 AM
Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire Inc. - 2/14/2019 6:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2019 4:35:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/8/2019 4:33:41 PM
New REDUCE-IT™ Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American Colleg... GlobeNewswire Inc. - 1/23/2019 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2019 4:43:20 PM
Amarin Provides Preliminary 2018 Results and 2019 Outlook GlobeNewswire Inc. - 1/4/2019 4:15:00 PM
Amarin to Present at 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 GlobeNewswire Inc. - 1/2/2019 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/30/2018 6:35:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/30/2018 6:34:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/29/2018 4:08:05 PM
Securities Registration (ads, Immediate) (f-6ef) Edgar (US Regulatory) - 11/29/2018 3:07:20 PM
Amarin to Participate in a Fireside Chat at Citi’s 2018 Global Healthcare Conference GlobeNewswire Inc. - 11/28/2018 6:25:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/28/2018 5:24:09 PM
Amarin Prices Public Offering of American Depositary Shares GlobeNewswire Inc. - 11/26/2018 8:59:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/26/2018 5:32:33 PM
Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire Inc. - 11/26/2018 4:23:58 PM
Amarin to Present at the Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/20/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/14/2018 6:03:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2018 6:18:24 AM
Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stro... PR Newswire (US) - 11/11/2018 10:32:00 AM
Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stro... GlobeNewswire Inc. - 11/10/2018 3:00:00 PM
Amarin to Present at the Jefferies 2018 London Healthcare Conference GlobeNewswire Inc. - 11/8/2018 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2018 4:13:25 PM
jfmcrr   Tuesday, 02/12/19 11:12:33 AM
Re: Biobillionair post# 175734
Post # of 177262 
Quote:
Don’t underestimate the relevant R-I study results creating a public safety issue regarding sham oxidized “fish oils”.—-BB





I don't see it as a serious health safety issue as compared to "energy compounds" or other herbal concoctions that lead to E room visits. More like "heart healthy" cooking oils, which, unlike what it sounds, don't do anything beneficial in terms of more making someone healthier. Warnings, yes. Going after "science has shown... AD or cancer claims, yes. Hammer Down/Wrath of the US Government, no.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist